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Background: Recent proteomic studies on
respiratory conditions investigate proteome
changes to identify protein biomarker can-
didates for diagnosis, monitoring and
treatment. A major challenge in clinical
proteomics is the limited patient material.
This is usually addressed by pooling
patients into disease groups. With sensitive
quantitative proteomics methods, like
iTRAQ (isobaric tag for relative and abso-
lute quantitation) technology, to identify
and quantify proteomic proﬁles with mass
spectrometry, it may be possible to deter-
mine individual patient proteome differ-
ences without the need for pooling. The
feasibility of this strategy is examined with
the identiﬁcation of proteins in bronchial
biopsies of asthma and COPD patients, in
an effort to identify disease and treatment
speciﬁc protein biomarker candidates.
Methods: Bronchial biopsies per patient,
per timepoint, were taken from asthmatic
(n = 14) and COPD (n = 16) subjects,
treated with budesonide or placebo, before
and after treatment. Healthy subjects
(n = 4) and healthy smokers (n = 4) were
used as controls. Biopsies were randomised
over 20 sets of 4-plex experiments with the
operator being blinded to the disease sta-
tus. Each 4-plex experiment contained a
common reference pool for normalisation
purposes. Proteins extracted from the biop-
sies were digested, labelled with iTRAQ
reagents and fractionated using cation
exchange chromatography, before each of
the fractions was subjected to reversed
phase nanoLC-MS/MS. The resulting spec-
tra were analysed by Proteome Discoverer
and the Swissprot database was searched
for protein identiﬁcations.
Results: Bronchial biopsies yielded a small,
but sufﬁcient amount of protein to conduct
proteomic experiments using iTRAQ tech-
nology. Sixty-ﬁve micrograms of protein
was digested, fractionated and analysed by
nanoLC-MS/MS. Early results showed that
more than 1000 proteins could be identiﬁed
with high statistical conﬁdence.
Conclusion: Small amounts of patient
bronchial biopsy material may be used to
identify and quantify proteins using the
iTRAQ technology with a highly sensitive
MS system, without the need for pooling
of samples from several patients. This
method may be used to identify airway dis-
ease speciﬁc mucosal biomarkers.
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Background: The cellular role in chronic
urticaria (CU) has been gradually recog-
nised, however the genetic determinism is
not well identiﬁed. The aim of this work
was to evaluate the inﬂuence of HLA
haplotype and the association of genetic
polymorphism of some cytokines in CU.
Methods: After signed informed consent,
in a 15 patients population (10 female,
mean age 45.7 ± 8.8 years and disease
evolution time of 6.5 ± 5.9 years), with
clinical criteria of CU and previous clinical
and laboratory evaluation, blood samples
were collected to assess class I (locus A
and B) and class II (locus DR) HLA
genetic typing and evaluate cytokine single
nucleotide polymorphisms (SNP’s) in the
promoter region of IL-1 (a,b,R,RA), IL-2,
IL-4, IL-6, IL-10, IL-12, IFN-c, TGF-b
and TNF-a. The results were compared
with a group of 174 healthy individuals
(group C).
Results: It was observed a higher genotype
frequency in locus A for A*26 (NS) and
A*68 (P = 0.048), while for A*01 (NS) it
was identiﬁed a lower frequency, comparing
with control group. In respect to locus B,
the allele B*51 was the most frequent (NS);
there was a higher frequency of B*38 in CU
comparing to group C (P = 0.047). For
class II, the alleles DRB1*04, DRB1*07 and
DRB1*15 were the most frequent, compar-
ing to group C, but without statistical signif-
icance. The most frequent haplotype was
the A*01 B*08 DRB1*03, as in group C;
however the second most frequent was A*02
B*51 DRB1*11, corresponding to the ﬁfth
most frequent of the controls (4.7% versus
1.4%, P 0.106). It was found a higher phe-
notype frequency for the following cytokine
SNP’s: IL10-592CC (P = 0.021), IL10-
819CC (P = 0.021), TNFa-308GG (P =
0.018), IL1a-889CC (P = 0.043), TGFb +
869CT (P < 0.0001), TGFb+915CG (P =
0.001) and IL2+166TT and GT (P = 0.014
and 0.020). On the other hand, there were
lower frequencies for IFNc+874TT
(P = 0.001), TGFb+915GG (P = 0.023),
IL2-166GG (P < 0.0001). In group CU
there were not ﬁnd heterozygous for TNFa-
238AG (P < 0.0001) and homozygous for
TNFa-308AA (P < 0.0001), TGFb +
869TT and +915CC (P < 0.0001 and
0.030), IL2-330TT (P = 0.002) and IL4-
1098TT and -33TT (P = <0.0001 and
0.014).
Conclusion: The haplotype and cytokine
SNP’s differences found suggest an immu-
nogenetic contribution in CU pathogenesis.
There were identiﬁed signiﬁcant changes in
cytokines of Th1 and Th2 response,
explaining the immunologic and clinical
complexity of this syndrome.
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Differential gene expression in the
sensitisation and tolerance to olive
pollen: microarray analysis
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Background: Microarrays studies could be
very useful in the identiﬁcation of new
routes or pathways that can discriminate
sensitization and natural or induced toler-
ance against allergens.
Methods: Subjects living in an area with
extremely high load of olive pollen were
collected in two exposition moments, high
pollen levels (pollen season) and low (out-
side pollen season) distributed in 5 Groups:
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